Your browser is no longer supported. Please, upgrade your browser.
FLXN Flexion Therapeutics, Inc. daily Stock Chart
FLXN [NASD]
Flexion Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.93 Insider Own1.60% Shs Outstand39.71M Perf Week-19.00%
Market Cap264.07M Forward P/E- EPS next Y-1.47 Insider Trans0.00% Shs Float36.86M Perf Month-55.25%
Income-149.80M PEG- EPS next Q-0.97 Inst Own- Short Float20.45% Perf Quarter-66.17%
Sales73.00M P/S3.62 EPS this Y12.50% Inst Trans0.19% Short Ratio9.52 Perf Half Y-49.96%
Book/sh-0.53 P/B- EPS next Y43.50% ROA-62.50% Target Price26.44 Perf Year-46.84%
Cash/sh3.44 P/C1.93 EPS next 5Y20.00% ROE-592.50% 52W Range5.01 - 22.98 Perf YTD-67.87%
Dividend- P/FCF- EPS past 5Y-14.90% ROI-78.50% 52W High-71.06% Beta1.96
Dividend %- Quick Ratio4.90 Sales past 5Y- Gross Margin86.30% 52W Low32.73% ATR1.14
Employees288 Current Ratio5.40 Sales Q/Q149.50% Oper. Margin- RSI (14)31.47 Volatility9.48% 16.18%
OptionableYes Debt/Eq- EPS Q/Q18.10% Profit Margin- Rel Volume0.78 Prev Close6.85
ShortableYes LT Debt/Eq- EarningsMar 12 AMC Payout- Avg Volume791.94K Price6.65
Recom1.80 SMA20-23.27% SMA50-51.03% SMA200-53.80% Volume615,954 Change-2.92%
Dec-27-19Reiterated The Benchmark Company Buy $19 → $25
Dec-05-19Initiated Craig Hallum Buy
Nov-25-19Initiated BTIG Research Buy $27
May-09-19Upgrade The Benchmark Company Hold → Buy $19
Jan-04-19Reiterated Needham Buy $42 → $36
Jan-04-19Downgrade The Benchmark Company Buy → Hold
Jun-28-18Initiated The Benchmark Company Buy $39
Oct-09-17Reiterated Needham Buy $36 → $42
Aug-24-17Initiated Northland Capital Outperform
Dec-22-16Initiated Raymond James Strong Buy
Sep-06-16Resumed Lake Street Buy $38
Jul-21-16Initiated Lake Street Buy $38
May-03-16Resumed Wells Fargo Outperform
Nov-04-15Initiated Cantor Fitzgerald Buy
Sep-09-15Reiterated Needham Buy $31 → $28
May-14-15Initiated Northland Capital Outperform $40
Mar-31-15Initiated MLV & Co Buy $38
Aug-14-14Initiated Summer Street Research Buy $25
Mar-10-14Initiated Needham Buy $26
Apr-03-20 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Apr-01-20 07:00AM  Flexion Therapeutics Announces ZILRETTA® License Agreement and Provides Business Update Amid Coronavirus Pandemic GlobeNewswire -10.93%
Mar-16-20 03:49PM  Edited Transcript of FLXN earnings conference call or presentation 12-Mar-20 8:30pm GMT Thomson Reuters StreetEvents -32.24%
Mar-14-20 08:55AM  Flexion Therapeutics, Inc. Just Released Its Full-Year Results And Analysts Are Updating Their Estimates Simply Wall St.
Mar-12-20 06:35PM  Flexion Therapeutics (FLXN) Reports Q4 Loss, Tops Revenue Estimates Zacks -17.55%
04:01PM  Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results GlobeNewswire
Mar-11-20 04:30PM  Flexion Therapeutics Names Melissa Layman Chief Commercial Officer GlobeNewswire -10.86%
Mar-06-20 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Mar-05-20 12:30PM  Will Flexion Therapeutics (FLXN) Report Negative Earnings Next Week? What You Should Know Zacks
Mar-04-20 04:30PM  Flexion Therapeutics to Report Fourth-Quarter and Full-Year 2019 Financial Results on March 12, 2020 GlobeNewswire
Feb-24-20 04:30PM  Flexion Therapeutics to Present at the 41st Annual Raymond James Institutional Investors Conference GlobeNewswire -6.24%
Feb-20-20 12:31PM  Flexion Therapeutics (FLXN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks
07:12AM  Have Insiders Been Buying Flexion Therapeutics, Inc. (NASDAQ:FLXN) Shares? Simply Wall St.
Feb-07-20 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jan-28-20 02:36PM  5 'Strong Buy' Biotech Stocks to Buy for 2020 Kiplinger
01:48PM  5 'Strong Buy' Biotech Stocks With Rapidly Approaching Catalysts Kiplinger
Jan-15-20 06:34AM  When Will Flexion Therapeutics, Inc. (NASDAQ:FLXN) Turn A Profit? Simply Wall St.
Jan-13-20 08:30AM  Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate Update GlobeNewswire
Jan-10-20 07:13AM  The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx Benzinga -10.48%
Jan-09-20 04:01PM  Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2019 Revenue and Initial Revenue Guidance for 2020 GlobeNewswire
Jan-03-20 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jan-01-20 06:00PM  Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates Benzinga
Dec-31-19 09:39AM  Is the Options Market Predicting a Spike in Flexion (FLXN) Stock? Zacks
Dec-30-19 09:44AM  Flexion's (FLXN) Stock Up on FDA Approval for Zilretta sNDA Zacks
Dec-27-19 04:36PM  Dow, S&P 500 rise as stocks extend record-setting rally MarketWatch +9.20%
02:53PM  Flexion Therapeutics soars on FDA label change approval Yahoo Finance Video
02:14PM  Flexion Therapeutics shares soar after FDA approves change to label on knee pain treatment MarketWatch
10:33AM  Flexion Analysts Say Long-Delayed Zilretta Label Expansion A Relief For Investors Benzinga
08:46AM  Benzinga Pro's Top 5 Stocks To Watch For Fri., Dec. 27, 2019: NKE, AXE, PT, FLXN, ZLAB Benzinga
08:02AM  Flexion Therapeutics stock soars 24% premarket as FDA approves label change for OA keen pain therapy MarketWatch
07:59AM  The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping Benzinga
05:47AM  Flexion Surges on FDA Label-Update Approval, Analyst Price-Target Lift TheStreet.com
Dec-26-19 04:15PM  Flexion Therapeutics Announces FDA Approval of sNDA to Revise ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Product Label GlobeNewswire
Dec-17-19 07:30AM  Flexion Therapeutics Enrolls First Patients in Phase 2 Trial of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in OA of the Shoulder and Adhesive Capsulitis GlobeNewswire
Dec-12-19 03:42PM  Should You Buy Flexion Therapeutics Inc (FLXN)? Insider Monkey
01:12PM  Should Investors Up the Ante on These 3 Strong Buy Stocks? TipRanks
Dec-10-19 09:00AM  Flexion Therapeutics Announces the Retirement of Neil Bodick, M.D., Ph.D., Chief Scientific Officer and Company Co-Founder GlobeNewswire
08:27AM  Flexion Therapeutics (NASDAQ:FLXN) Shareholders Have Enjoyed A 40% Share Price Gain Simply Wall St.
Dec-09-19 09:00AM  Flexion Therapeutics to Host Physician Event at Orthopaedic Summit 2019 Featuring Panel of Former Professional Athletes Treated With ZILRETTA® for Osteoarthritis Knee Pain GlobeNewswire
Dec-06-19 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Nov-17-19 07:14AM  Edited Transcript of FLXN earnings conference call or presentation 7-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-11-19 07:30AM  Flexion Therapeutics Presents ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Efficacy Data at the AAHKS and ACR Annual Meetings GlobeNewswire
Nov-07-19 07:15PM  Flexion Therapeutics (FLXN) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM  Flexion Therapeutics Reports Third-Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
Nov-04-19 07:48AM  Before You Buy Flexion Therapeutics, Inc. (NASDAQ:FLXN), Consider Its Volatility Simply Wall St.
Nov-01-19 04:40PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Oct-31-19 04:30PM  Flexion Therapeutics to Report Third-Quarter 2019 Financial Results on November 7, 2019 GlobeNewswire
02:20PM  Is Flexion Therapeutics Inc (FLXN) A Good Stock To Buy? Insider Monkey
07:30AM  Flexion Therapeutics Announces FDA Clearance of the Investigational New Drug Application for FX201, a Gene Therapy Candidate for the Treatment of Osteoarthritis GlobeNewswire
Oct-14-19 07:00AM  Flexion Therapeutics Announces Extended FDA Review of Supplemental New Drug Application for ZILRETTA® GlobeNewswire
12:17AM  3 Top Biotech Stocks With Major Catalysts in October TipRanks
Oct-13-19 04:33PM  The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings Benzinga
Oct-11-19 08:56AM  Do Options Traders Know Something About Flexion Therapeutics (FLXN) Stock We Don't? Zacks
Oct-04-19 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
08:40AM  Health Check: How Prudently Does Flexion Therapeutics (NASDAQ:FLXN) Use Debt? Simply Wall St.
Oct-02-19 09:00AM  Former NY Yankees Outfielder Chris Dickerson Teams Up With Flexion Therapeutics to Raise Awareness of Impact of Osteoarthritis (OA) GlobeNewswire
Sep-30-19 09:04AM  Flexion Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa GlobeNewswire
Sep-23-19 09:00AM  Flexion Therapeutics Sponsors a Memorial to the Victims of the Opioid Crisis to Raise Awareness of the Tragic Consequences of the Opioid Epidemic Across the U.S. GlobeNewswire
Sep-18-19 09:31AM  Buy These 7 Small Drugmakers to Boost Your Portfolio's Health Zacks
Sep-10-19 07:36AM  The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris Benzinga +7.06%
Sep-09-19 04:01PM  Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexions Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain GlobeNewswire
Sep-06-19 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Sep-04-19 09:55AM  Flexion Therapeutics, Inc. (FLXN) Shares March Higher, Can It Continue? Zacks
08:23AM  Need To Know: Flexion Therapeutics, Inc. (NASDAQ:FLXN) Insiders Have Been Buying Shares Simply Wall St.
Sep-03-19 02:21PM  In expense-laden biotech industry, here are the Mass. startups most in need of cash American City Business Journals
Aug-28-19 04:30PM  Flexion Therapeutics to Present at the Wells Fargo Securities 2019 Healthcare Conference GlobeNewswire
Aug-10-19 12:01PM  3 Healthcare Stocks With Rising Expectations Motley Fool
Aug-07-19 05:45PM  Edited Transcript of FLXN earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents +11.71%
04:26PM  Flexion Therapeutics, Inc. (FLXN) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 06:35PM  Flexion Therapeutics (FLXN) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM  Flexion Therapeutics Reports Second-Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
Aug-05-19 08:53AM  How Should Investors Feel About Flexion Therapeutics, Inc.'s (NASDAQ:FLXN) CEO Pay? Simply Wall St.
Aug-02-19 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire -7.16%
Jul-30-19 04:30PM  Flexion Therapeutics to Report Second-Quarter 2019 Financial Results on August 6, 2019 GlobeNewswire
10:38AM  Will Flexion Therapeutics (FLXN) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-15-19 07:30AM  Flexion Therapeutics Presents New Data Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in Patients with Advanced Knee OA GlobeNewswire +6.12%
Jul-05-19 06:47AM  Flexion Therapeutics, Inc. (NASDAQ:FLXN): When Will It Breakeven? Simply Wall St.
Jul-03-19 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jun-24-19 01:28PM  Heres What Hedge Funds Think About Flexion Therapeutics Inc (FLXN) Insider Monkey -6.44%
Jun-20-19 09:00AM  Flexion Therapeutics Named one of Boston Business Journals Best Places to Work for the Third Consecutive Year GlobeNewswire
Jun-18-19 04:30PM  Flexion Therapeutics to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference GlobeNewswire
Jun-07-19 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jun-06-19 02:27PM  Edited Transcript of FLXN earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents
Jun-05-19 08:30AM  Flexion Therapeutics Announces Issuance of New U.S. Patent Covering FX201 a Gene Therapy Product Candidate for the Treatment of Osteoarthritis GlobeNewswire
May-30-19 06:58AM  If You Had Bought Flexion Therapeutics (NASDAQ:FLXN) Stock A Year Ago, You'd Be Sitting On A 56% Loss, Today Simply Wall St.
May-20-19 12:48PM  These 3 Small-Cap Healthcare Stocks Reported Big Updates This Month Motley Fool
May-14-19 04:30PM  Flexion Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference GlobeNewswire
May-12-19 09:50PM  Heres What Hedge Funds Think About Flexion Therapeutics Inc (FLXN) Insider Monkey
May-10-19 01:06PM  Flexion Therapeutics, Inc. (FLXN) Q1 2019 Earnings Call Transcript Motley Fool +8.74%
07:30AM  Flexion Therapeutics Announces Publication of Pooled Analysis of Phase 2/3 Data on Use of Rescue Medication with ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) GlobeNewswire
May-09-19 11:58AM  Here's Why Flexion Therapeutics Jumped as Much as 18.4% Today Motley Fool +19.32%
09:45AM  Chevron, Conduent, Flexion, and More: Stocks in the Spotlight Insider Monkey
May-08-19 06:35PM  Flexion Therapeutics (FLXN) Reports Q1 Loss, Lags Revenue Estimates Zacks -5.47%
05:25PM  Flexion Therapeutics: 1Q Earnings Snapshot Associated Press
04:01PM  Flexion Therapeutics Reports First-Quarter 2019 Financial Results and Recent Business Highlights GlobeNewswire
02:30PM  Flexion Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
May-03-19 04:30PM  Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-02-19 09:00AM  Flexion Therapeutics Announces Upcoming Presentations at the 2019 Osteoarthritis Research Society International (OARSI) World Congress GlobeNewswire
May-01-19 04:30PM  Flexion Therapeutics to Report First-Quarter 2019 Financial Results on May 8, 2019 GlobeNewswire
Apr-25-19 07:58AM  The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings Benzinga
Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201 a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MAHAFFY PATRICK JDirectorAug 29Option Exercise0.1630,8244,93230,824Aug 29 04:46 PM
Willwerth ChristinaChief Strategy OfficerAug 13Option Exercise0.168,7501,40067,169Aug 14 04:06 PM
Clayman Michael D.President and CEOAug 08Buy10.852,31725,13672,249Aug 08 04:38 PM
COLELLA SAMUEL DDirectorAug 08Buy10.742,00021,48045,333Aug 09 04:05 PM
Arkowitz DavidChief Financial OfficerMay 31Buy11.052,50027,62789,424Jun 03 04:18 PM
MERRIFIELD C ANNDirectorMay 23Buy12.648,000101,12010,000May 24 09:15 AM
Arkowitz DavidChief Financial OfficerMay 13Buy11.994,00047,96086,924May 15 04:05 PM
Clayman Michael D.President and CEOMay 10Buy12.484,01250,06774,868May 13 09:15 AM
Arkowitz DavidChief Financial OfficerMay 08Sale10.062,24822,61582,924May 09 04:32 PM